|
18 Companies |
|
21 Products |
|
21 Products |
|
21 Mechanisms of Action |
|
1 Trial |
|
51 News |
|
| «12 |
- dovitinib (TKI258) / Novartis, Oncoheroes
New P2 trial, Metastases: Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma (clinicaltrials.gov) - Jan 19, 2012
P2, N=17, Active, not recruiting, Sponsor: Spanish Oncology Genito-Urinary Group